Aehr Test Systems [NASDAQ: AEHR] gained 32.08% or 5.54 points to close at $22.81 with a heavy trading volume of 9178170 shares. The company report on January 5, 2023 that Aehr Receives Follow-on Production Order for FOX-XP Multi-Wafer Test and Burn-in System with Integrated Automated WaferPak Aligner from Major Silicon Carbide Semiconductor Customer.
Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor production test and reliability qualification equipment, today announced it has received a follow-on production order from its second major silicon carbide semiconductor customer for an additional production FOX-XPTM multi-wafer test and burn-in system configured with Aehr’s fully integrated and automated WaferPakTM Aligner.
The FOX-XP system is configured with Bipolar Voltage Channel Module (BVCM) and Very High Voltage Channel Module (VHVCM) options that enable new advanced test and burn-in capabilities for silicon carbide power semiconductors using Aehr’s proprietary WaferPak full wafer Contactors. This customer serves several significant markets including the electric vehicle industry as well as other industrial applications. The FOX-XP system with integrated WaferPak Aligner is expected to ship in Aehr’s fiscal fourth quarter that begins March 1, 2023.
It opened the trading session at $21.00, the shares rose to $24.99 and dropped to $21.00, the range by which the price of stock traded the whole day. The daily chart for AEHR points out that the company has recorded 202.52% gains over the past six months. However, it is still -239.94% lower than its most recent low trading price.
If we look at the average trading volume of 1.84M shares, AEHR reached to a volume of 9178170 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Aehr Test Systems [AEHR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AEHR shares is $31.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AEHR stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Aehr Test Systems shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 17, 2022.
The Average True Range (ATR) for Aehr Test Systems is set at 2.08, with the Price to Sales ratio for AEHR stock in the period of the last 12 months amounting to 8.50. The Price to Book ratio for the last quarter was 12.07, with the Price to Cash per share for the same quarter was set at 1.73. Price to Free Cash Flow for AEHR in the course of the last twelve months was 431.73 with Quick ratio for the last quarter at 4.30.
Trading performance analysis for AEHR stock
Aehr Test Systems [AEHR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.57. With this latest performance, AEHR shares gained by 0.66% in over the last four-week period, additionally plugging by 202.52% over the last 6 months – not to mention a rise of 12.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AEHR stock in for the last two-week period is set at 54.19, with the RSI for the last a single of trading hit 58.78, and the three-weeks RSI is set at 52.88 for Aehr Test Systems [AEHR]. The present Moving Average for the last 50 days of trading for this stock 22.66, while it was recorded at 19.30 for the last single week of trading, and 14.38 for the last 200 days.
Aehr Test Systems [AEHR]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Aehr Test Systems [AEHR] shares currently have an operating margin of +15.35 and a Gross Margin at +46.56. Aehr Test Systems’s Net Margin is presently recorded at +18.59.
Return on Equity for this stock inclined to 30.27, with Return on Assets sitting at 22.50.
Aehr Test Systems’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.30 and a Current Ratio set at 6.00.
Aehr Test Systems [AEHR]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AEHR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Aehr Test Systems go to 20.00%.
An analysis of insider ownership at Aehr Test Systems [AEHR]
There are presently around $275 million, or 44.30% of AEHR stock, in the hands of institutional investors. The top three institutional holders of AEHR stocks are: AWM INVESTMENT COMPANY, INC. with ownership of 1,648,319, which is approximately 0.061% of the company’s market cap and around 4.90% of the total institutional ownership; FMR LLC, holding 1,350,945 shares of the stock with an approximate value of $30.82 million in AEHR stocks shares; and VANGUARD GROUP INC, currently with $25.82 million in AEHR stock with ownership of nearly 8.59% of the company’s market capitalization.
Positions in Aehr Test Systems stocks held by institutional investors increased at the end of January and at the time of the January reporting period, where 57 institutional holders increased their position in Aehr Test Systems [NASDAQ:AEHR] by around 4,224,959 shares. Additionally, 31 investors decreased positions by around 926,944 shares, while 13 investors held positions by with 6,914,877 shares. The mentioned changes placed institutional holdings at 12,066,780 shares, according to the latest SEC report filing. AEHR stock had 30 new institutional investments in for a total of 2,855,127 shares, while 16 institutional investors sold positions of 300,367 shares during the same period.